Examples of using Package leaflets in English and their translations into Greek
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Official/political
-
Computer
The package leaflets should be updated accordingly.
These are supplied in the package leaflets for those medicines.
Amendments to the Summaries of Product Characteristics and Package Leaflets.
You should also read the package leaflets for these medicines.
Amendments to relevant sections of the summary of product characteristics and the package leaflets.
Labelling of medicinal products and package leaflets[COM(89) 607 final- SYN 231].
See the package leaflets for these medicines for additional information on their use and effects.
Corresponding changes were made to the package leaflets.
See also the package leaflets for peginterferon alfa and ribavirin.
Grounds for amendment of the summaries of product characteristics, package leaflets and labelling.
It will start appearing in the package leaflets of the medicines concerned from the autumn of 2013.
Annex III Amendments to relevant sections of the summaries of product characteristics and package leaflets.
It is important that you also read the package leaflets for these other medicines.
Read the package leaflets for these other medicines for information regarding driving and using machines.
It is very important that you read the package leaflets that are provided with these medicines too.
Read the package leaflets for these medicines for their dosage and directions on‘how to take' them.
Scientific conclusions andgrounds for amendment of the summaries of product characteristics and package leaflets.
Therefore, these SmPCs,labelling and package leaflets may not necessarily represent the current text.
All references to the above mentioned indications should be deleted from the relevant sections of the package leaflets.
Refer also to the package leaflets of any other medicines that are used in combination with Pegasys.
Annex III Amendments to relevant sections of the summaries of product characteristics and package leaflets.
Please refer to the Package Leaflets of these other medicines for guidance on how to take them.
Scientific conclusions and grounds for amendment of the summaries of product characteristics,labelling and package leaflets.
If you are unsure of any information in the package leaflets, please contact your doctor or pharmacist.
Read the package leaflets for the other medicines used for treating your hepatitis C infection for side.
The amended Summaries of Product Characteristics and package leaflets of the reference Member State are set out in Annex III.
More information on the restrictions on the use of medicines radiolabelled with Yttriga will be found in their package leaflets.
The CHMP recommended amendments to the relevant sections of the Summary of product characteristics and Package leaflets of the medicinal products containing cabergoline and pergolide(see Annex III).
Grounds for the addition of three manufacturing sites to the marketing authorisations andamendment of the summaries of product characteristics and package leaflets.
The committee agreed the harmonisation of the summary of product characteristics,labelling and package leaflets proposed by the marketing authorisation holder.